Christine Sapan is Chief Development Officer at NEUROLOGIX INC/DE (NRGX). They have made 1 open-market trade across 1 company since 2006, most recently 2006-12-15.
CIK 0001368619
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NRGX | 7,500 | $152K |
Shares reported on the most recent Form 4, priced at the 2006-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NRGX | BUY | 2006-12-15 | 2006-12-19 | $0.64 | $6K | +3.8% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.